CLINICAL · AI SCRIBE

Psychiatric History Intake with an AI Scribe: Turning Your Longest Appointment Into Your Best-Documented One

Published March 19, 2026

The psychiatric intake evaluation is the most documentation-intensive appointment in mental health practice. A comprehensive intake — covering history of present illness, past psychiatric and medical history, family history, social history, substance use, developmental history, mental status exam, risk assessment, diagnostic formulation, and treatment plan — routinely generates 3–5 pages of clinical documentation. For prescribing providers like psychiatrists and PMHNPs, this note also establishes the foundation for every medication decision that follows.

Most clinicians spend 45–90 minutes after their intake sessions completing this documentation. Some schedule lighter afternoons after intake days just to catch up on charting. An AI scribe changes that equation — not by shortcutting the clinical process, but by capturing and organizing the information as the session unfolds, so the note is substantially complete before the patient leaves.

Why Intake Notes Take So Long

Intake evaluations are different from follow-up sessions in several ways that compound the documentation burden:

Volume of information: You're gathering a complete psychiatric history in a single session — chief complaint, HPI, past psychiatric history (medications tried, hospitalizations, previous diagnoses), medical history, family psychiatric history, social/developmental history, substance use, and trauma screening. Each section requires careful documentation.
Diagnostic complexity: The intake is where you establish differential diagnoses with DSM-5 specifiers, rule-out conditions, and document the clinical reasoning that supports your diagnostic formulation. This isn't a checkbox — it requires narrative clinical justification.
Medication decision rationale: If you're prescribing at the intake, you need to document why you chose a specific medication, why alternatives were not selected, what the patient's prior medication trials showed, and what your risk-benefit analysis considered. Auditors and peer reviewers evaluate this section closely.
Baseline establishment: The intake MSE and symptom severity scores (PHQ-9, GAD-7, PCL-5, AUDIT-C, etc.) establish the baseline against which all future progress is measured. Incomplete or vague baselines undermine your ability to demonstrate treatment effectiveness.
Informed consent documentation: Risks, benefits, and alternatives for the proposed treatment plan — particularly for medication — must be documented, along with the patient's understanding and agreement.

The result is that intake notes are typically 3–5x longer than follow-up session notes, and clinicians consistently rank them as their biggest documentation pain point.

What an AI Scribe Captures During a Psychiatric Intake

An AI scribe listens to the session in real time and organizes what it hears into the sections of your intake template. Here's what a well-designed psychiatric intake AI scribe captures across the standard intake sections:

Chief Complaint & History of Present Illness (HPI)

The patient's reason for seeking treatment, in their own words, along with onset, duration, severity, aggravating/alleviating factors, and functional impact. The AI captures the patient's narrative and structures it chronologically.

Example:34-year-old female presenting for initial psychiatric evaluation with chief complaint of "I can't stop worrying and it's affecting my work." Onset approximately 6 months ago, coinciding with promotion to management role. Reports persistent worry about job performance, health of family members, and finances. Symptoms present most days, with difficulty controlling worry. Associated symptoms include muscle tension (neck/shoulders), difficulty concentrating at work, irritability with partner, and initial insomnia (takes 1–2 hours to fall asleep). Functional impact: missed 3 work days in the past month, declined social invitations, and reports strain on relationship. Previously managed anxiety with exercise and journaling but reports these strategies are no longer sufficient. No prior psychiatric treatment.

Past Psychiatric History

Previous diagnoses, prior medication trials (with doses, duration, response, and reason for discontinuation), therapy history, psychiatric hospitalizations, and suicide attempt history. This section is critical for medication decision-making.

Example:No prior psychiatric diagnoses. No previous psychotropic medications. Attended 6 sessions of counseling in college (2014) for adjustment to academic stress — reports it was helpful but discontinued when symptoms resolved. No psychiatric hospitalizations. No history of suicide attempts or self-harm. Denies prior ECT, TMS, or ketamine treatment.

Medical, Family & Social History

The AI captures medical comorbidities, current medications, allergies, family psychiatric history (with specific diagnoses and relationships), and social history including living situation, relationships, employment, education, and substance use. It also documents trauma history and developmental factors when discussed.

Example: Medical: Hypothyroidism (levothyroxine 50mcg daily, last TSH within normal limits per patient), seasonal allergies (cetirizine PRN). NKDA. Family psych: Mother — generalized anxiety disorder (treated with sertraline); maternal grandmother — "nervous breakdown" in her 40s (details unknown); father — no known psychiatric history; brother — ADHD (diagnosed childhood). Social: Lives with partner of 4 years. Works as project manager at tech company (recently promoted). Bachelor's degree in communications. No children. Substance use: Social alcohol (2–3 drinks/week, no binge pattern), denies tobacco, cannabis, or illicit substance use. AUDIT-C: 2. Trauma: Denies history of physical, sexual, or emotional abuse. No significant childhood adversity reported.

Mental Status Exam (MSE)

The AI generates a structured MSE from behavioral observations during the session — appearance, psychomotor activity, speech, mood and affect, thought process, thought content, perceptions, cognition, insight, and judgment. For prescribers, this is a required component that supports the diagnostic formulation and documents the patient's presentation at baseline.

Example:Appearance: Well-groomed, appropriately dressed for the season, appears stated age. Psychomotor: No agitation or retardation; fidgeting noted when discussing work stress. Speech: Normal rate and volume; slightly pressured when describing worry content. Mood: "Anxious and overwhelmed." Affect: Anxious, mildly restricted range, congruent with stated mood. Tearful briefly when discussing impact on relationship. Thought process: Linear and goal-directed; occasional tangentiality when describing worry themes (redirectable). Thought content: Preoccupied with performance at work and health concerns. No delusions, obsessions, or phobias identified. Perceptions: Denies auditory, visual, or other hallucinations. Cognition: Alert and oriented x4. Attention intact to conversation. Memory grossly intact for recent and remote events. Insight: Good — recognizes that worry is excessive and seeking help appropriately. Judgment: Good — making protective decisions (seeking treatment, maintaining employment). SI/HI: Denies suicidal ideation, homicidal ideation, and self-harm urges. No plan, intent, or means identified. Safety factors: supportive partner, employment, treatment engagement.

Assessment & Diagnostic Formulation

The AI generates a diagnostic impression with DSM-5 criteria mapping, differential diagnoses with supporting and refuting evidence, and a clinical formulation that integrates the biopsychosocial picture. This is where the clinical reasoning lives.

Example: Primary: Generalized Anxiety Disorder (F41.1) — meets DSM-5 criteria: excessive worry more days than not for >6 months, difficulty controlling worry, 4/6 associated symptoms (muscle tension, difficulty concentrating, irritability, sleep disturbance), clinically significant functional impairment (occupational, social, relational). Rule out: Adjustment Disorder with Anxiety (F43.22) — temporal relationship to promotion is notable, but symptom severity and pervasiveness exceed what would be expected for an adjustment reaction. Social Anxiety Disorder (F40.10) — anxiety is not limited to social/performance situations; worry themes extend to health and finances. Medical considerations: Hypothyroidism adequately treated per patient report; recommend verifying recent TSH. Risk level: Low. No SI/HI, no substance misuse, strong protective factors.

Treatment Plan

The plan section documents medication decisions with rationale, therapy recommendations, labs, referrals, safety planning, and follow-up timing.

Example:1) Start sertraline 25mg daily x 7 days, then increase to 50mg daily. Selected based on family history of response (mother), favorable side-effect profile, and efficacy for GAD. Discussed expected timeline (2–4 weeks for initial response, 6–8 weeks for full effect), common side effects (GI upset, headache, initial anxiety increase), and rare risks (serotonin syndrome, activation, bleeding risk). Patient verbalized understanding. 2) Refer for individual therapy — CBT recommended for GAD. Provided three referrals in network. 3) Labs: Request recent TSH from PCP to confirm thyroid stability. CBC, CMP, lipid panel for baseline. 4) Sleep hygiene education provided (stimulus control, consistent wake time, limit screens). 5) Safety plan not indicated at this time — no SI/HI identified. Will reassess at each visit. 6) Follow-up in 3 weeks to assess medication tolerability and titration. Patient agreeable to plan.

What Changes for the Clinician

The clinical encounter itself doesn't change. You still conduct a thorough psychiatric history, observe the patient, form a diagnostic impression, and develop a treatment plan. What changes is what happens after the session:

Review instead of recreate: Instead of reconstructing the session from memory and brief handwritten notes, you review an AI-generated draft that captured the information as it was discussed. Your role shifts from writer to editor.
Structured automatically: The AI organizes information into the correct intake template sections. Patient history doesn't end up in the MSE. Medication rationale lands in the plan. You're not spending mental energy on structure — only on clinical accuracy.
Better baselines: Because the AI captures symptom severity scores, direct quotes, and detailed MSE observations in real time, baseline documentation tends to be more thorough than notes written from recall. This pays dividends at every subsequent visit when you need to measure progress.
More present in the session: When you're not mentally cataloging what to write down later, you can be more attentive to the patient. Several clinicians report that their intake conversations became more natural and exploratory after they stopped taking detailed notes during the session.

Privacy and Compliance for Intake Documentation

Intake sessions contain the highest concentration of sensitive information in any clinical encounter — trauma history, substance use details, family psychiatric history, and developmental experiences. Any AI scribe handling this data must meet strict compliance requirements:

HIPAA compliance: The AI scribe must operate under a Business Associate Agreement (BAA) and meet all HIPAA security requirements for PHI handling, including encryption in transit and at rest.
No training on patient data: Audio and session content should never be used to train AI models. This is non-negotiable for mental health documentation.
Informed consent: Patients should be informed that AI-assisted documentation is being used and give their consent before the session begins. MH Scribe provides a guide for introducing AI documentation to patients and a downloadable consent form template.
Clinician review required: The AI generates a draft. The clinician reviews, edits, and signs the final note. Clinical judgment and responsibility remain with the provider.

Choosing an Intake Template

Not all intake templates are equivalent. Your choice should reflect your role and clinical setting. Common intake formats include:

Psychiatric Evaluation (prescribers): Full HPI, past psychiatric history, medication history with trial details, medical/surgical history, family history, social history, substance use, MSE, risk assessment, diagnostic formulation with differentials, and medication plan with rationale. This is the standard for psychiatrists, PMHNPs, and PAs.
Psychotherapy Intake (therapists): Presenting problem, relevant history, psychosocial assessment, clinical impressions, and treatment goals. Typically shorter on medication detail, more detailed on psychosocial factors, coping strategies, and therapeutic goals.
Integrated intake (combined prescriber + therapist): For clinicians who both prescribe and provide therapy, a combined template captures both medication management elements and psychotherapy-focused assessment.

MH Scribe ships with a Psychiatric Intake template alongside SOAP, DAP, BIRP, and GIRP — and you can create fully custom templates to match any intake format your practice requires. The AI adapts its note structure to whichever template you select, organizing session content into the correct sections automatically. For a comparison of session note formats, see our SOAP vs DAP notes guide or the full template comparison.

Spend Your Intake Doing Clinical Work, Not Charting

MH Scribe generates comprehensive psychiatric intake notes from your session — structured, coded, and ready for review. Start free with 5 AI notes.